V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196042 | 20125072 | 1.65 | 92.2 | null | 2017-01-12 | 2019-09-28 | Trastuzumab | 02 | null | TRASTUZUMAB | 100362173 |
| 20196043 | 20125073 | 1.75 | 97 | Palliative (P) | 2017-08-21 | 2017-08-27 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101652372 |
| 20196049 | 20125074 | 1.7 | 82.4 | Palliative (P) | 2017-02-26 | 2017-04-02 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101163416 |
| 20196051 | 20125075 | 1.59 | 70.6 | Palliative (P) | 2019-01-02 | 2019-01-26 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100070925 |
| 20196052 | 20125076 | 1.75 | 40.6 | null | 2019-02-14 | 2019-03-07 | CETUXIMAB | 02 | null | CAPECITABINE + CISPLATIN | 101222963 |
| 20196053 | 20125077 | 1.96 | 53.9 | Palliative (P) | 2017-03-10 | 2017-03-16 | CETUXIMAB | 02 | N | CETUXIMAB | 100041751 |
| 20196055 | 20125078 | 1.74 | 59.1 | null | 2016-04-25 | 2016-05-14 | CETUXIMAB | 02 | null | CETUXIMAB | 100683753 |
| 20196056 | 20125079 | 1.62 | 62.7 | Neo-adjuvant (N) | 2017-02-16 | 2017-03-15 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100875740 |
| 20196065 | 20125080 | 1.76 | 75 | Palliative (P) | 2016-03-19 | 2016-04-08 | TRASTUZUMAB | 02 | N | CETUXIMAB | 101143406 |
| 20196068 | 20125081 | 1.49 | 60 | Curative (C) | 2016-11-11 | 2016-11-24 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100971027 |
| 20196069 | 20125082 | 1.66 | 58 | 03 | 2017-04-26 | 2017-06-01 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100505413 |
| 20196073 | 20125083 | 1.57 | 71 | Palliative (P) | 2018-06-17 | 2018-07-15 | CETUXIMAB | 02 | N | CETUXIMAB | 101109889 |
| 20196075 | 20125084 | 1.74 | 77.9 | null | null | 2018-07-22 | Trastuzumab 21 day maintenance | 2 | null | TRASTUZUMAB | 100642379 |
| 20196076 | 20125085 | 1.7 | 73.75 | null | 2017-02-06 | 2017-02-14 | CETUXIMAB | null | null | CETUXIMAB | 101831628 |
| 20196080 | 20125086 | 1.85 | 77 | Curative (C) | 2020-02-15 | 2020-02-29 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100276674 |
| 20196084 | 20125087 | 1.76 | 90.85 | Palliative (P) | null | 2016-04-10 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 100511933 |
| 20196091 | 20125088 | 1.67 | 55.4 | Curative (C) | null | 2020-04-12 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 100507443 |
| 20196092 | 20125089 | 1.61 | 64.75 | Neo-adjuvant (N) | null | 2020-03-16 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101168770 |
| 20196096 | 20125090 | 1.7 | 77 | Adjuvant (A) | 2019-09-23 | 2019-09-23 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101084562 |
| 20196100 | 20125091 | 1.83 | 64 | Palliative (P) | 2018-07-10 | 2018-07-10 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 100058455 |
| 20196104 | 20125092 | 1.93 | 54.8 | Curative (C) | 2017-11-28 | 2017-11-28 | Trastuzumab | 02 | N | TRASTUZUMAB | 100821808 |
| 20196112 | 20125093 | 1.73 | 71.8 | null | null | 2020-01-02 | Cetuximab 7 day (Cycle 1) | 02 | null | CETUXIMAB | 100898841 |
| 20196113 | 20125094 | 1.56 | 64.1 | Palliative (P) | 2021-05-16 | 2021-05-30 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100012528 |
| 20196114 | 20125095 | 1.61 | 65.3 | null | 2016-08-29 | 2016-09-12 | CETUXIMAB | 02 | null | TRASTUZUMAB | 100943119 |
| 20196117 | 20125096 | 1.65 | 46.6 | Palliative (P) | 2015-12-14 | 2016-04-07 | CETUXIMAB | 02 | N | CETUXIMAB | 101588551 |
| 20196122 | 20125097 | 1.75 | 62.6 | Palliative (P) | 2017-10-31 | 2017-12-01 | Cetuximab 7 day (Cycle 1) | 02 | N | CETUXIMAB | 101731193 |
| 20196123 | 20125098 | 1.82 | 83.4 | Palliative (P) | 2018-10-09 | 2019-03-14 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100610303 |
| 20196129 | 20125099 | 1.83 | 53.75 | Palliative (P) | 2016-09-02 | 2016-09-14 | Trastuzumab | 02 | N | TRASTUZUMAB | 100685441 |
| 20196130 | 20125100 | 1.77 | 69 | Neo-adjuvant (N) | 2018-02-08 | 2018-02-08 | CETUXIMAB | 02 | null | CAPECITABINE + CISPLATIN | 100550422 |
| 20196133 | 20125101 | 1.87 | 85.4 | Palliative (P) | 2019-07-04 | 2019-07-26 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101390566 |
| 20196135 | 20125102 | 1.84 | 64 | null | 2018-10-11 | 2018-10-25 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100122123 |
| 20196137 | 20125103 | 1.85 | null | Palliative (P) | 2019-09-23 | 2019-10-12 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101563005 |
| 20196140 | 20125104 | 1.59 | 79 | Neo-adjuvant (N) | 2019-06-25 | 2019-07-03 | CETUXIMAB | 02 | N | CETUXIMAB | 101403064 |
| 20196141 | 20125105 | 1.82 | 101 | Palliative (P) | 2019-11-25 | 2020-01-24 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100884311 |
| 20196142 | 20125106 | 1.88 | 63.15 | Palliative (P) | 2019-12-05 | 2020-02-17 | CETUXIMAB | 02 | Y | CETUXIMAB | 101100562 |
| 20196147 | 20125107 | 1.77 | 56.6 | null | 2019-01-04 | 2019-01-15 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 101088029 |
| 20196149 | 20125108 | 1.75 | 70.3 | Curative (C) | null | 2017-03-20 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100988001 |
| 20196155 | 20125109 | 1.73 | 75 | Curative (C) | null | 2016-11-26 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101053525 |
| 20196159 | 20125110 | 1.77 | 98 | Adjuvant (A) | 2016-12-27 | 2016-12-27 | Trastuzumab 21 day loading dose | 02 | Y | TRASTUZUMAB | 100323594 |
| 20196161 | 20125111 | 1.73 | 77 | Curative (C) | 2016-09-06 | 2016-09-22 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100014688 |
| 20196164 | 20125112 | 1.77 | 73.2 | Palliative (P) | 2017-09-24 | 2017-09-25 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100613073 |
| 20196167 | 20125113 | 1.73 | 106.6 | Palliative (P) | 2017-08-18 | 2018-01-13 | CETUXIMAB | 02 | N | CETUXIMAB | 101143430 |
| 20196169 | 20125114 | 1.8 | 86.4 | Palliative (P) | 2019-10-26 | 2019-10-30 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101726389 |
| 20196174 | 20125115 | 1.72 | 88.2 | Palliative (P) | 2018-02-02 | 2018-02-09 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101683605 |
| 20196178 | 20125116 | 1.66 | 90 | Palliative (P) | 2017-12-17 | 2019-07-11 | CETUXIMAB | 02 | N | CETUXIMAB | 100015199 |
| 20196179 | 20125117 | 1.64 | 62.2 | Palliative (P) | 2018-01-05 | 2018-08-19 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101658520 |
| 20196183 | 20125118 | 1.83 | 75 | Palliative (P) | 2017-05-14 | 2018-05-01 | TRASTUZUMAB | N | N | CETUXIMAB | 101663607 |
| 20196185 | 20125119 | 1.51 | 77.3 | Palliative (P) | 2018-07-06 | 2018-08-06 | Trastuzumab | 02 | N | TRASTUZUMAB | 101510410 |
| 20196190 | 20125120 | 1.65 | 45.4 | null | 2016-06-04 | 2016-06-27 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 100957844 |
| 20196191 | 20125121 | 0 | 78.15 | Palliative (P) | null | 2020-03-25 | CETUXIMAB | 02 | N | CETUXIMAB | 100126076 |